NovoCure
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell NovoCure and other ETFs, options, and stocks.About NVCR
NovoCure Ltd. is an oncology company which engages in the development, manufacture, and commercialization of Optune for the treatment of a variety of solid tumors. Its platform is called the Tumor Treating Field which uses electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division.
NVCR Key Statistics
Stock Snapshot
The current NovoCure(NVCR) stock price is $10.75, with a market capitalization of 1.2B. The stock trades at a price-to-earnings (P/E) ratio of -8.63.
As of 2026-04-03, NovoCure(NVCR) stock has fluctuated between $10.30 and $10.87. The current price stands at $10.75, placing the stock +4.4% above today's low and -1.1% off the high.
The NovoCure(NVCR)'s current trading volume is 1.15M, compared to an average daily volume of 1.26M.
During the past year, NovoCure(NVCR) stock moved between $9.82 at its lowest and $20.06 at its peak.
During the past year, NovoCure(NVCR) stock moved between $9.82 at its lowest and $20.06 at its peak.
NVCR News
In late March 2026, Novocure reported that its Phase 2 PANOVA-4 trial showed Tumor Treating Fields therapy combined with atezolizumab and gemcitabine/nab-paclit...
Advertisement NovoCure stock moves after recent performance shifts NovoCure (NVCR) is back on many investors’ screens after a recent stretch of weaker share p...
Analyst ratings
75%
of 8 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.